CARDIOTOXICITY OF STREPTOCOCCAL PYROGENIC EXOTOXINS
链球菌热原性外毒素的心脏毒性
基本信息
- 批准号:2218234
- 负责人:
- 金额:$ 13.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-07-01 至 1997-08-31
- 项目状态:已结题
- 来源:
- 关键词:Streptococcus infection Streptococcus pyogenes affinity chromatography cardiotoxin crystallization epitope mapping exotoxins immunotoxicity laboratory rabbit lipopolysaccharides medical complication molecular pathology monoclonal antibody mutant nucleic acid sequence polymerase chain reaction protein purification protein structure function pyrogens rheumatic fever site directed mutagenesis superantigens synthetic peptide toxic shock syndrome vascular endothelium
项目摘要
Cardiac complications including cardiomyopathy and endocarditis
frequently complicate HIV infections particularly late in the course of
the disease. Injection drug users infected with HIV are the most
commonly affected. The etiology of HIV-related cardiotoxicity is
unclear, although some believe it is related to concurrent infection with
other bacterial and viral pathogens. This grantee is studying the
cardiotoxicity of streptococcal pyrogenic enterotoxins and staphylococcal
endotoxins on the heart. The long term goals of this project are two
fold: 1) to evaluate the role of streptococcal pyrogenic exotoxins in
causing both acute toxic shock line illnesses and delayed sequelae such
as acute rheumatic fever and vascular diseases and 2) to analyze the
structure function relationships among the streptococcal pyrogenic
enterotoxins and staphylococcal enterotoxin. It is hoped that the latter
studies will ultimately clarify the molecular mechanism of action of the
toxins.
R01HL42125
The objective of this program is to continue and expand ongoing studies
on the mechanism by which pyrimidine nucleoside analog active against HIV
such as 3'azido-3'-deoxythymidine and congeners exert toxicity on bone
marrow and other cells. The elicitation of these mechanisms may permit
the development of a combination therapy with modulating agents that
protect or reverse host toxicity without impairment of the anti-HIV
activity of the drug under scrutiny. This project has two major aims:
1) the description of the biochemical and molecular mechanism responsible
for the effects of AZT and its metabolite, 3'-amino-3'-deoxythymidine
(AMT) in human marrow cells; and 2) the detailed characterization of the
enzymatic reduction of AZT to AMT in human hepatocytes with the
evaluation of potential drug-drug interactions through the cytochrome P-
450 pathway.
心脏并发症,包括心肌病和心内膜炎
艾滋病病毒感染经常并发症,特别是在病程后期,
这种疾病 注射吸毒者感染艾滋病毒的人数最多
普遍受到影响。 HIV相关心脏毒性的病因是
尚不清楚,尽管有些人认为这与并发感染有关,
其他细菌和病毒病原体。 该受赠方正在研究
链球菌致热原肠毒素和葡萄球菌肠毒素的心脏毒性
内毒素对心脏的影响 该项目的长期目标有两个
倍数:1)评价链球菌致热性外毒素在
引起急性中毒性休克和延迟后遗症,
急性风湿热和血管疾病; 2)分析
致热原链球菌结构与功能关系的研究
肠毒素和葡萄球菌肠毒素。 希望后者
研究将最终澄清的分子机制的行动,
毒素
R01HL42125
该计划的目标是继续和扩大正在进行的研究
嘧啶核苷类似物抗HIV活性的机制
例如3 ′叠氮基-3 ′-脱氧胸苷和对骨产生毒性同类物
骨髓和其他细胞。 这些机制的激发可能允许
与调节剂的联合治疗的开发,
保护或逆转宿主毒性而不损害抗HIV
药物的活性受到审查。 该项目有两个主要目标:
1)生物化学和分子机制的描述
AZT及其代谢物3 '-氨基-3'-脱氧胸苷的作用
(AMT)在人骨髓细胞中;和2)
人肝细胞中AZT酶促还原为AMT
评价通过细胞色素P-
450路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick M Schlievert其他文献
Patrick M Schlievert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick M Schlievert', 18)}}的其他基金
Staphylococcal superantigen and anthrax inhibitors
葡萄球菌超抗原和炭疽抑制剂
- 批准号:
8376957 - 财政年份:2012
- 资助金额:
$ 13.71万 - 项目类别:
Staphylococcal superantigen and anthrax inhibitors
葡萄球菌超抗原和炭疽抑制剂
- 批准号:
8233349 - 财政年份:2011
- 资助金额:
$ 13.71万 - 项目类别:
Staphylococcal superantigen and anthrax inhibitors
葡萄球菌超抗原和炭疽抑制剂
- 批准号:
7672097 - 财政年份:2009
- 资助金额:
$ 13.71万 - 项目类别:
MWCE: Transmission/Pathogenesis of Bioterrorism Agents
MWCE:生物恐怖主义制剂的传播/发病机制
- 批准号:
6698883 - 财政年份:2003
- 资助金额:
$ 13.71万 - 项目类别:
MWCE: Transmission/Pathogenesis of Bioterrorism Agents
MWCE:生物恐怖主义制剂的传播/发病机制
- 批准号:
6797820 - 财政年份:2003
- 资助金额:
$ 13.71万 - 项目类别:
相似国自然基金
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
- 批准号:31770069
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
The impact of environmental conditions on the prevalence and aerosol transmission of Streptococcus pyogenes
环境条件对化脓性链球菌流行和气溶胶传播的影响
- 批准号:
2879696 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Studentship
Discovery of a pigment produced by Streptococcus pyogenes
发现化脓性链球菌产生的色素
- 批准号:
10680293 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Molecular basis for transmission of Streptococcus pyogenes
化脓性链球菌传播的分子基础
- 批准号:
MR/X001962/1 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Research Grant
Investigating CovRS activation within skin microenvironments to drive heterogenicity of Streptococcus pyogenes gene expression
研究皮肤微环境中的 CovRS 激活以驱动化脓性链球菌基因表达的异质性
- 批准号:
10751462 - 财政年份:2023
- 资助金额:
$ 13.71万 - 项目类别:
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
化脓性链球菌对β-内酰胺类抗生素敏感性降低的分子基础
- 批准号:
10596614 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Defining the mechanisms underlying the development of adaptive immunity to Streptococcus pyogenes
定义化脓性链球菌适应性免疫发展的机制
- 批准号:
2749193 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Studentship
Molecular basis of decreased susceptibility to beta-lactam antibiotics in Streptococcus pyogenes
化脓性链球菌对β-内酰胺类抗生素敏感性降低的分子基础
- 批准号:
10449481 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Class II bacteriocins of Streptococcus pyogenes
化脓性链球菌 II 类细菌素
- 批准号:
RGPIN-2019-04785 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Discovery Grants Program - Individual
Macrophage Immunosuppression by Quorum-Induced Streptococcus pyogenes
群体诱导化脓性链球菌对巨噬细胞的免疫抑制
- 批准号:
10442806 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:
Macrophage Immunosuppression by Quorum-Induced Streptococcus pyogenes
群体诱导化脓性链球菌对巨噬细胞的免疫抑制
- 批准号:
10655477 - 财政年份:2022
- 资助金额:
$ 13.71万 - 项目类别:














{{item.name}}会员




